Monica Shaw
Direktor/Vorstandsmitglied bei AC IMMUNE SA
Vermögen: 20 954 $ am 30.04.2024
Aktive Positionen von Monica Shaw
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AC IMMUNE SA | Direktor/Vorstandsmitglied | 29.10.2021 | - |
| Independent Dir/Board Member | 29.10.2021 | - | |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 06.09.2023 | - |
| The Royal College of Physicians | Corporate Officer/Principal | - | - |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Corporate Officer/Principal | - | - |
| ViiV Healthcare Co. | Corporate Officer/Principal | - | - |
Karriereverlauf von Monica Shaw
Ehemalige bekannte Positionen von Monica Shaw
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ONCOPEPTIDES AB | Vorstandsvorsitzender | 04.01.2023 | 07.08.2023 |
| Novartis AG /U.S. Biologics Manufacturing Operation/ | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Monica Shaw
| Oxford University Medical School | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Vereinigtes Königreich | 3 |
| Schweiz | 2 |
Operativ
| Corporate Officer/Principal | 4 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| AC IMMUNE SA | Health Technology |
| ONCOPEPTIDES AB | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private Unternehmen | 3 |
|---|---|
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
| ViiV Healthcare Co. | |
| Novartis AG /U.S. Biologics Manufacturing Operation/ | Health Technology |
- Börse
- Insiders
- Monica Shaw
- Erfahrung
